Statistics for Investigation of Pre-clinical and Phase II clinical studies of VLP-58-1023- AL-K3-PII vaccine for Alpha variant
Total visits
| views | |
|---|---|
| Investigation of Pre-clinical and Phase II clinical studies of VLP-58-1023- AL-K3-PII vaccine for Alpha variant | 22 |
Total visits per month
| views | |
|---|---|
| October 2024 | 2 |
| November 2024 | 6 |
| December 2024 | 1 |
| January 2025 | 8 |
| February 2025 | 1 |
| March 2025 | 1 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| B161233.pdf | 67 |
Top country views
| views | |
|---|---|
| Japan | 6 |
| Turkey | 5 |
| United States | 3 |
| Australia | 2 |
| China | 2 |
| Hong Kong SAR China | 2 |
| Ireland | 1 |
| India | 1 |
Top city views
| views | |
|---|---|
| Osaka | 6 |
| Boardman | 3 |
| Izmir | 3 |
| Hong Kong | 2 |
| Sydney | 2 |
| Ankara | 1 |
| Beijing | 1 |
| Dublin | 1 |
| Sincan | 1 |